StockNews.com cut shares of Kura Oncology (NASDAQ:KURA – Free Report) from a hold rating to a sell rating in a research note issued to investors on Monday. KURA has been the topic of several other research reports. Mizuho began coverage on shares of Kura Oncology in a research report on Friday, December 22nd. They set […]